Table 4 The association between periostitis and voriconazole by age.

From: Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database

Age,years

N

χ2

RRR (95% CI)

PRR (95% CI)

ROR (95% CI)

IC (95% CI)

 < 18

4

582.0

191.7 (56.2, 653.8)

446.1 (100.0, 1990.0)

448.1 (100.1, 2005.4)

7.5 (5.7, 8.6)

18–65

87

39,262.2

457.8 (348.7, 601.0)

1503.7 (1028.3, 2199.0)

1531.7 (1045.1, 2244.6)

8.8 (8.4, 9.1)

 > 65

31

14,057.9

469.7 (292.7, 753.7)

2545.2 (1121.7, 5775.4)

2573.1 (1132.1, 5848.2)

8.9(8.3, 9.3)

  1. RRR relative reporting ratio, CI confidence interval, PRR proportional reporting ratio, ROR reporting odds ratio, IC information components.
Back to article page